Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Ronald, Pruitt"'
Autor:
Stanislas Pol, M. Beumont-Mauviel, Gaston Picchio, Christophe Hézode, Antonio Olveira, Marc Bourlière, Marc Bifano, Adrián Gadano, Stephanie Noviello, Kin Cheung, Joerg Petersen, Ronald Pruitt, Jean-Pierre Bronowicki, Eric Hughes, F. Gea, Mihály Makara, Dominique Thabut, Tivadar Bányai, Maria Buti, Fiona McPhee, M. Tarek Al-Assi, Navdeep Boparai, Stefan Zeuzem, Véronique Loustaud-Ratti, Sivi Ouwerkerk-Mahadevan
Publikováno v:
Journal of Hepatology
Journal of Hepatology, 2016, 64 (2), pp.292-300. ⟨10.1016/j.jhep.2015.09.024⟩
Journal of Hepatology, Elsevier, 2016, 64 (2), pp.292-300. ⟨10.1016/j.jhep.2015.09.024⟩
Journal of Hepatology, 2016, 64 (2), pp.292-300. ⟨10.1016/j.jhep.2015.09.024⟩
Journal of Hepatology, Elsevier, 2016, 64 (2), pp.292-300. ⟨10.1016/j.jhep.2015.09.024⟩
International audience; BACKGROUND & AIMS:We evaluated the combination of daclatasvir (pan-genotypic NS5A inhibitor) and simeprevir (NS3/4A protease inhibitor), with or without ribavirin, in hepatitis C virus genotype 1-infected patients.METHODS:This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31e4ef64cdd9f8996473bd0574365a3d
https://hal.univ-lorraine.fr/hal-01659111
https://hal.univ-lorraine.fr/hal-01659111
Autor:
Stuart C. Gordon, Rvikumar Vemuru, Mark Eisner, Jay Cowan, James Ehrlich, Alain Ades, Clifford A. Brass, Micheal David Bernstein, Steve Chen, Donald Hillebrand, Donald Wadland, Lyle Shlager, C. Smith, Lou Gelrud, Mark Levstik, Helen Wong, Stephen A. Harrison, Andrew Nelson, Raj Bhandari, David Dies, Mordechai Rabinovitz, Edward A. Galen, B. Freilich, K. Digregorio, Curt Hagendom, Thomas Hargrave, Paul Bermanski, David Maccini, Samuel B. Ho, Ronald Pruitt, Terence Reisman, Thomas Allen, Robert S. Brown, Michael Cox, David Schulman, Ramsey Cheung, Fred Kilby, J. Lynn Cochran, Thomas McDonald, James Thornton, John Jolley, John Serini, Albert D. Min, Fredrich Loura, Lino Deguzman, Luis Marsano, Robert Finkel, Helen S. Te, Michael G Rahmin, Mark Jonas, Kip Lyche, Jean Luc Szpakowski, George Abraham, Alex D. Lee, Pabak Mukhopadhyay, Firdous Siddiqui, Robert Strauss, William Kaplan, Michael Ryan, Eliot Godofsky, Stephen J. Lanspa, Lawton Shick, Jose Franco, Louis Griffel, Rise Stribling, Avanish Aggarwal, Clive Albert, Thomas Rosenfield, Rockford Yapp, Vijay Balan, Arthur Berman, Nezam H. Afdhal, Maurice Cerulli, Paul Yudelman, Robert Herring, Donate Ricci, Michael Henry, Michael Bloom, Daniel Meline, Barry Migicovsky, Peter Varunok, Peter W Gardner, Gerald Siciliano, Natarjan Bala, Craig J. Peine, P. Kwo, Thomas Noble, David F. Stein, Thuan T. Nguyen, Geoffrey Zucker, Julie E Spivack, John Kichner, Robert G. Gish, Michael Fried, Murali Shankar, Norman Gitlin, James E. Nelson, David Hurwich, Darrell Schwertner, Ronald Wasserman, Douglas D. Dalke, Thai Van Pham, Geronimo Sahagun, Norah A. Terrault, Naoky Tsai, Steven Han, Tarek Hassanein, Thomas Sepe, Seth Richter, Howard Paul Monsour, Micheal Lyons, R. Agrawal, Bennett Cecil, Joseph Polito, Douglas Levin, James Srour, Allan Weston, Larry Weprin, Raymond Kenny, Edward Lebovics, Michael Demicco, Terry Box, Kenneth Diamond, Lawrence Kim, Stephen Kelly, Martin Black, Jeffrey Fenyves, Ellen Shaw, Raymond A. Rubin, James E. Cox, Franco Felizarta, John E. Gross, Ira Lobis, David H. Van Thiel, Bonnie Bock, Lawrence Stein, James D. Lewis, Steven Palley, Ronald Rinker, Joanna Ready, Vinod K. Rustgi, Michael Epstein, David H Berman, Gary Matusow, Walid Baddoura, Gerond Lake-Bakaar, John S. Goff, Scott Wiesen, Neil Brodsky, Fredric Regenstein, Arnold Levin, Bhupinder S. Anand, Stephen Esposito, K. Rajender Reddy, Lisa Ozick, Adil E. Wakil, Karl Esrason, Pierre Nader, David Nunes, David Feldman, K. Ganeshappa, Alan Fixelle, Martha Ghosh, Douglas Brouillette, Victor Araya, Hillel Tobias, David Pound, Louis R. Lambiase, S. Lawrence Rothman, Mark J. Murphy, Jonathan David, James Levin, Steve Carlson, Nathan Kam, Michael S. Dragutsky, Trong Nguyen Tuan, Graham Woolf, Whit Knapple, Donna Goldman, Kenneth R. DeVault, Simon Cofrancesco, Mitchell L. Shiffman, Charles Bedard, Paul Y. Kwo, Rodger Perez, Steven L. Flamm, Keith Tolman, Hulya Levendoglu, Timothy Cavacini, Robert Reindollar, Vance VanDrake, Donald M. Jensen, David Winston, Robert A. Levine, Robert Manning, John R. Lake, John J. Santoro, Scott Becker, Mary Pat Pauly, John M. Vierling, Joseph DePasquale, Jorge Herrera, Diana Sylvestre, Natarajan Ravendhran, Mark Smith, Kevin Dye, M. Davis, Frank Klion, Kevin Behrle, Alan Epstein, William Lyles, Brian K. Hudes, Greg Galler, David I. Bernstein, Jonathon Jensen, Jeffery Cooley, Thomas J. Layden, Carl D'Angelo, Fredric D. Gordon, Myron Brand, David Gabbazaideh, Leon Rigberg, Neville R. Pimstone, Jonathan McCone, Ira M. Jacobson, Tim M Jenkins, John W. King, Harry Matossian, William A. Ross, Rudra Rai
Publikováno v:
Hepatology. 46:971-981
This prospective, multicenter, community-based and academic-based, open-label, investigator-initiated, U.S. study evaluated efficacy and safety of pegylated interferon (PEG-IFN) alfa-2b plus a flat or weight-based dose of ribavirin (RBV) in adults wi
Autor:
Severine Vermeire, Sharon Spence, Brenda Lemos, Sally Kennedy, Theadore Ptak, Barbara S. Fox, M. Scott Harris, Deborah Hartman, Emma C. Erlich, Ronald Pruitt
Publikováno v:
Journal of Crohn'scolitis. 10(6)
Background and aims: AVX-470 is an oral, polyclonal bovine-derived anti-tumour necrosis factor (TNF) antibody in development for treatment of inflammatory bowel disease (IBD). AVX-470 neutralizes TNF locally in the gastrointestinal tract, minimizing
Autor:
Ronald Pruitt, David Sales, George Koval, John K Bell, Dennis Riff, Lawrence Wruble, Lorin K Johnson, Douglas S. Levine
Publikováno v:
The American Journal of Gastroenterology. 97:1398-1407
A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis
Autor:
L. Nilsson, Tore Persson, Lloyd P. Haskell, Malcolm Robinson, Ronald Pruitt, Karen Walton–Bowen, Stephen B. Hanauer, Audrey J. Lazenby, Jeffrey G. Levine
Publikováno v:
Gastroenterology. 115:525-532
Background & Aims: Budesonide is a highly potent topical glucocorticosteroid that is characterized by low systemic availability as a result of high first-pass hepatic metabolism. The aim of this study was to evaluate the efficacy and safety of three
Autor:
Michael Safdi, John S. Hanson, Pamela Doty, Lorin K. Johnson, George Koval, John Johanson, Amanda Cross, Ronald Pruitt, Robert Hardi, Barry Winston, Lawrence Wruble, Dennis Riff
Publikováno v:
The American journal of gastroenterology. 97(12)
Balsalazide is a novel azo-bonded 5-aminosalicylic acid treatment for mild-to-moderate ulcerative colitis. The study objective was to compare symptomatic remission rates with balsalazide and mesalamine while controlling for extent of disease and time
Autor:
Douglas S, Levine, Dennis S, Riff, Ronald, Pruitt, Lawrence, Wruble, George, Koval, David, Sales, John K, Bell, Lorin K, Johnson
Publikováno v:
The American journal of gastroenterology. 97(6)
Balsalazide is a new innovative, mesalamine-containing prodrug that is activated by bacteria in the colon. Balsalazide has been shown previously to be well tolerated and effective in the treatment of acute ulcerative colitis. The aim of this study wa
Autor:
Srinadh Komanduri, Ronald Pruitt, Daniel S. Camara, V. Raman Muthusamy, Herbert C. Wolfsen, George Triadafilopoulos, Gary W. Chmielewski, Atilla Ertan, Anthony Infantolino, William D. Lyday, Charles J. Lightdale, Bergein F. Overholt, Richard I. Rothstein, F. Scott Corbett, Nicholas J. Shaheen, William J. Bulsiewicz
Publikováno v:
Gastrointestinal Endoscopy. 75:AB460
Autor:
Walter H. Jacobs, David Cort, Bernard J. Powers, Sessions Jt, Cerda Jj, Simon K. Lo, Ronald Pruitt, Sninsky Ca, Fergus Shanahan, Targan
Publikováno v:
Annals of internal medicine. 115(5)
Objective To evaluate the efficacy and safety of a pH-sensitive, polymer-coated oral preparation of mesalamine in patients with mildly to moderately active ulcerative colitis. Design A multicenter, double-blind, placebo-controlled randomized trial. S
Autor:
PR Newswire
Publikováno v:
PR Newswire US. 04/24/2020.